Conflict of Interest Reporting Improves Among IRB Members According to JAMA…
A study published in JAMA this month looked into the frequency of industry relationships among members of Institutional Review…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
FDA Communication Regulations Hurt Competition
We previously reported on Amarin’s lawsuit against the FDA, arguing that its restrictive interpretations of off-label speech would…
Open Payments 2014 Data Highlights
The 2014 Open Payments database covers 11.41 million transactions between manufacturers and covered recipients (physicians and…
Novartis in the News: Blockbuster Heart Failure Drug Entresto Approved,…
Novartis has been in the news a fair amount recently—both for good and bad reasons. Starting with the good, the company’s heart…
House of Representatives Approves 21st Century Cures Act 344-77
The U.S. House of Representatives today approved H.R. 6, the 21st Century Cures Act, by a vote of 344-77. The bill…
Here We Go Again: Open Payments Round 2, and Planning For Disclosure, by…
Seth Whitelaw is President and CEO of Whitelaw Compliance Group, LLC.
On the first of July, the Centers for Medicare and…
PatientsLikeMe Teams With FDA To Explore Patient-Reported Adverse Events
During last month's DIA Annual meeting in Washington, D.C., online patient community PatientsLikeMe announced a research…
“Quality” Measures Update
According to CMS, more than 460,000 of the 1.25 million eligible Medicare providers did not meet deadlines to submit data for the…
AstraZeneca and Cephalon Agree to Pay $46.5 Million and $7.5 Million,…
The Department of Justice announced recently that AstraZeneca agreed to pay the United States and participating states a…
Hotel Worker Union Protests Industry-Funded CME Soon After Blacklisted…
Source: Unite Here!
After calling for boycotts of multiple medical meetings in…